179 related articles for article (PubMed ID: 12550754)
1. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa.
Vos M; Adams CH; Victor TC; van Helden PD
Cancer Genet Cytogenet; 2003 Jan; 140(1):23-30. PubMed ID: 12550754
[TBL] [Abstract][Full Text] [Related]
2. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
3. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
4. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
5. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
[TBL] [Abstract][Full Text] [Related]
6. Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population.
Zaahl MG; Warnich L; Victor TC; Kotze MJ
Cancer Genet Cytogenet; 2005 May; 159(1):48-52. PubMed ID: 15860357
[TBL] [Abstract][Full Text] [Related]
7. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
8. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa.
Gamieldien W; Victor TC; Mugwanya D; Stepien A; Gelderblom WC; Marasas WF; Geiger DH; van Helden PD
Int J Cancer; 1998 Nov; 78(5):544-9. PubMed ID: 9808520
[TBL] [Abstract][Full Text] [Related]
9. Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand.
Thongsuksai P; Boonyaphiphat P; Puttawibul P; Sudhikaran W
World J Gastroenterol; 2010 Nov; 16(42):5359-66. PubMed ID: 21072901
[TBL] [Abstract][Full Text] [Related]
10. A nonsense mutation (Arg-196-Term) in exon 6 of the human TP53 gene identified in small cell lung carcinoma.
Hayes VM; Oosthuizen CJ; Kotze MJ; Marx MP; Buys CH
Mol Cell Probes; 1996 Oct; 10(5):393-5. PubMed ID: 8910896
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of TP53 mutations in bladder carcinoma.
Williamson MP; Elder PA; Knowles MA
Genes Chromosomes Cancer; 1994 Feb; 9(2):108-18. PubMed ID: 7513540
[TBL] [Abstract][Full Text] [Related]
12. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and internal tandem duplication mutations of the CBP gene are frequent events in human esophageal squamous cell carcinoma.
So CK; Nie Y; Song Y; Yang GY; Chen S; Wei C; Wang LD; Doggett NA; Yang CS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):19-27. PubMed ID: 14734447
[TBL] [Abstract][Full Text] [Related]
14. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
[TBL] [Abstract][Full Text] [Related]
15. TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis.
Neves Filho EH; Cordeiro DE; Vieira AP; Rabenhorst SH
Pathobiology; 2012; 79(6):323-8. PubMed ID: 22688387
[TBL] [Abstract][Full Text] [Related]
16. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
[TBL] [Abstract][Full Text] [Related]
17. [p53 gene codon 72 polymorphism and susceptibility to esophageal squamous cell carcinoma in a Chinese population].
Zhang L; Xing D; He Z; Lin D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):10-3. PubMed ID: 11836677
[TBL] [Abstract][Full Text] [Related]
18. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in larynx cancer.
Zhang LF; Hemminki K; Szyfter K; Szyfter W; Söderkvist P
Carcinogenesis; 1994 Dec; 15(12):2949-51. PubMed ID: 8001261
[TBL] [Abstract][Full Text] [Related]
20. Use of TP53 reference materials to validate mutations in clinical tissue specimens by single-strand conformational polymorphism analysis.
Sunar-Reeder B; Atha DH; Aydemir S; Reeder DJ; Tully L; Khan AR; O'Connell CD
Mol Diagn; 2004; 8(2):123-30. PubMed ID: 15527327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
